The panel agrees that OpenAI and Anthropic's 'safety' narrative is partly driven by financial concerns, specifically managing capital expenditure expectations ahead of IPOs. However, there's no consensus on the dominant factor (genuine safety risk, financial desperation, or competitive moat-building).
Risk: Regulation becoming selective, protecting OpenAI/Anthropic while strangling open-source competitors, and potentially stranding hyperscaler capex.
Opportunity: Hyperscalers' ability to monetize AI through existing enterprise workflows and software services, even with slower frontier progress.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Rachel Warren, and Travis Hoium discuss:
- OpenAI, Anthropic, and more sound the AI alarm.
- A safety problem or a business fundamentals problem.
- Consumer discretionary stocks: Value or value trap?
- AI is accelerating drug discovery.
- Mailbag: How important are dividends? …
Read more
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Rachel Warren, and Travis Hoium discuss:
- OpenAI, Anthropic, and more sound the AI alarm.
- A safety problem or a business fundamentals problem.
- Consumer discretionary stocks: Value or value trap?
- AI is accelerating drug discovery.
- Mailbag: How important are dividends?
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
A full transcript is below.
Should you buy stock in Amazon right now?
Before you buy stock in Amazon, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amazon wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $383,680! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,382,954!
Now, it’s worth noting Stock Advisor’s total average return is 937% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of September 27, 2026. *
This podcast was recorded on Sept. 14, 2026.
Tyler Crowe: AI leaders are looking for the brake pedal. Motley Fool Hidden Gems Investing starts now. Welcome to Motley Fool Hidden Gems Investing. I'm your host, Tyler Crowe. Today, I’m joined by longtime Fool contributors, Rachel Warren and Travis Hoium, doing a little bit of a mix-up. There has been a fair share of “we need to slow AI development“ chatter out there. But this past weekend, that conversation appeared to hit a fever pitch. We had several employees leaving Anthropic and OpenAI over safety concerns. Now both Sam Altman and Dario Amodei are calling for the slowing down of development of frontier models lest they go out of control, I think was the words that Sam Altman used. Even the CIO of the hedge fund Bridgewater Associates was on podcasts over the past week, talking about human extinction, and the probability was higher than 10%, which is silly if you think about it, or startling depending on how you want to look at it. This isn't anything new, but it does appear to come at a very specific time where both OpenAI and Anthropic are on the precipice of IPOs and spending on these businesses is getting tougher to swallow, especially at the frontier level, where the bulk of their spending is going. The cynical view, at least to me, is that all of this slowdown chatter comes at a time when they want to slow down spending more than anything else without disrupting business growth.
I want to pose the question to both of you. On a scale of AI will be the death of us we need to slow down, and we're trying to middle this spending versus growth challenges of business, where do you land on the spectrum here?
Rachel Warren: Honestly, I think the truth is probably somewhere in the middle, but I do tend to take a bit of a more cynical view to what we've been hearing. I want to talk about why. I think there’s a lot of calculations going on behind the scenes, and I don’t think that means that there aren’t real, justifiable concerns about AI safety and the constraints, or lack thereof, of some of these frontier labs. But I also think you have to look at the math behind all of this. You talk about OpenAI and anthropic. You're moving out of the easy bunny venture phase. These are companies that are anticipating to have huge entrances into the public markets, where they're going to face a very different level of scrutiny than they have in the private space.
Infrastructure spending has become a real black hole. You look at OpenAI's internal projections, which were reported not that long ago by the information, they're expecting a $14 billion loss. 2026, they could have cumulative losses of about 44 billion by 2028. Think about how a single next-gen data center runs about $35 billion on its own. This is not something that Wall Street is necessarily going to be forgiving on. Talking about Anthropic for a moment. We have heard for a while now from Dario Amodei. He's been spending almost the last year warning the industry to slow down.
Meanwhile, we also saw a report from the information that Anthropic has locked in $517 billion in compute commitments. That's 14.8 gigawatts of capacity. It's enough to rival just for scale a dozen nuclear reactors. They're funding that obviously with revenue. They have their confidential IPO pipeline. A lot of that is going to Alphabet, Amazon, Microsoft, SpaceX. The outside voices that are making this case as well have a lot of ski in the game. We had an interview with Greg Jensen that we saw from Bridgewater in recent days. He's not a neutral bystander. He was one of the earlier investors in both OpenAI and Anthropic. He's the one that was telling Bloomberg on a recent podcast there's a 30-60% chance of a catastrophic AI disaster in the next few years. Bridgewater's own SEC filings show that it's been building up positions in video Broadcom, Amazon. We're seeing this push for regulation in compliance costs, but it's more likely to just price out the open-source community and the small players who can't afford the legal overhead. The biggest labs can absorb it. I think the risks are very likely real. I'm more inclined to believe that there are justifiable concerns there. But I also think the loudest voices calling for caution are the same people holding the largest stakes; you have to question what the motivation is.
Travis Hoium: We're in such an interesting time with this entire debate, and from an investment perspective, we're talking about trillions of dollars in many multi-trillion dollar companies that are involved here. This isn't something that we should take lightly. As I reflect on the weekend, it was so interesting to see, first of all, the leaders of these labs almost all agree with what Dario wrote. That was a little bit stark to me and it felt a little bit coordinated. I don't know whether that's good or bad. But I also came away thinking that all of these things can be true. They can be really worried about safety. Critics can be correct in that they're just trying to pull the ladder up and get regulatory capture so that they can build a mote around their business. Everyone can also be wrong about all of those things.
These companies are crying wolf a little bit because they've been doing this for years. Dario Amodei has been one of the biggest critics, and yet he started a company that is now arguably in the lead in AI development and also thinks that this is going to lead to some terrible. There's a lot of cognitive dissonance going on here, and the history of technology says that something bad will probably happen. We just don't know what that is. When the Internet was invented, we didn't necessarily think that was going to lead to more isolation and mental health issues among younger people, but this is where we are today. The root cause and the cause and effect is unknown here. I think that's the real challenge is that it's almost like these people are saying, hey, you got to protect me from myself, because if I continue to develop this, I'm going to do something really bad.
One of the things that's most resonant to me is that there are laws in place for a lot of these things. If you build a product that goes out and hurts people or steals things, it is your fault. I almost wonder, too, if after this hugging face incident, my understanding is that there were laws broken. There were felonies committed and is OpenAI. We just seem to be glossing over that. If the next big thing is suddenly financial institutions are broken into and these AIs steal money, are people going to go to jail, and that's what they're worried about? It all is a very interesting and complicated push and pull of many things that are probably have threads of truth but are not completely true.
Ultimately, we're investors here. Something bad is probably going to happen. The question is going to be, then what are we going to do? Because, especially in the U.S., we don't typically act first. We act after the thing happens, and that's probably I can go back to the great financial crisis anything in the last 20 or 30 years, at least. That's just the way that I think it's probably going to play out. I think that's what regulators are looking at. That's what the president says, as well. A lot of uncertainty, but take these risks very seriously, but also ask questions about who is bringing them up.
Tyler Crowe: I got to say, hearing all of this, I feel like reading the S-1 for anthropic and OpenAI of seeing in the risk sections like, our AI agents might commit felonies, and we don't know if it might happen. I don't normally read the entire risk section line for line, but I might have to if this is what we're going to find. But you guys touched on a point I want to drill down a little bit deeper into here. You're talking about this little bit more, the idea of regulating AI development, stuff like that. It really feels like the Silicon Valley playbook that we've seen before, where it's this land and expand role of like you saw with Google, where it dominated search, or Meta, where it started to dominate social media. Then what ends up happening is regulations come down. Think about GDPR in Europe. Or something along those lines where the regulatory burdens are put up, and it's the idea of trying to make it more fair. But what ends up happening is these giants are the only ones that can handle the regulatory compliance to make it happen. I am curious to get your specific point, do you think this may actually just be like a regulatory thing? It's like we have pushed ourself far enough ahead of other people that we want to drop the drawbridge now and then use the regulatory advantage to our benefit, or is this more like the money side of it?
Travis Hoium: I think it's a nice happenstance that it also is to their competitive advantage if the ladder is pulled up. I don't necessarily think. Anthropic in particular, but I think all the AI developers, in general, this sounds crazy. Again, we're an investing podcast, but there is much more of a religious view to this in a lot of ways because they don't really know how this thing works. They can't explain to you why AI is doing the things that it's doing. There is this ineffable view that they have of this technology that they're developing. That's why I think they're very serious about being concerned. Oh, by the way, if it happens to help our business, that's a nice byproduct.
Rachel Warren: Look, the genie is out of the bottle, so to speak. I think there's multiple ways to look at this. I think I was pretty clear about. I have a cynical take in the sense that I think a lot of this unity that we're seeing among the leaders of these frontier labs goes back to the reality that the bottlenecks are their concerns about growth as they enter the public markets and trying to set expectations. But I do also think that we see that these leaders are talking about a technology that they have helped to create and develop that is rapidly outpacing their ability to control and even fully understand it. That creates a very difficult paradigm to unlock, because how do you regulate something that is evolving and learning so quickly?
At least in the short term, the answer is, you have to pull the brakes a bit. You have to scale back development, to understand how to regulate it. If they are watching somebody's recent incidents, obviously, the hugging face one is one of the most prominent. There could be a real concern about what liability could look like for these businesses moving on to the next three, five years and beyond. I think it's both to their benefit and of course, more broadly for the benefit of mankind for there to be regulation, but that is a much more difficult type of technology to actually set real legal guardrails around than what we've seen come out of Silicon Valley in the past. I think that is part of why this is so challenging.
Travis Hoium: Tyler, I just want to bring up one quick thing. I wonder if something happened at one of these labs that we don't yet know.
Rachel Warren: Can I get a report?
Travis Hoium: We didn't know about the Hugging Face incident until long after it happened.
Rachel Warren: Could be.
Travis Hoium: Is there a reason that all these people who seem to be fighting each other to lead the AI world? Why are they suddenly all on the same page? Just bringing that up.
Tyler Crowe: Waiting two months from now for the big news drop. He's like, there was an oops at OpenAI or something like that. Something that we're all going to be following, and not exactly the most cheaper way to start your Monday is, hey, AI might kill us, but maybe it's just for regulatory compliance purposes. But I promise we're going to do a little bit more of a palette cleanser here in the next segment.
ADVERTISEMENT: You just found out that your sales team is at risk of missing quota. Don't panic. Just ask Rippling AI. Since it's built on your real time people and business data, Rippling AI can pull metrics from Rippling and Salesforce into a meeting ready dashboard showing quota attainment, headcount plan, and monthly revenue to quota by region. In seconds, you'll see exactly what's behind your quota risk and fix it before it's missed. Question answered, action taken, crisis averted. When you have critical business questions that need answers, don't just file a ticket and wait weeks for an outdated report. Describe what you need and have Rippling AI build it instantly from your live people and business data, whether it's a dashboard with detailed charts or automated workflows with the right triggers, conditions, and approvals. Ready to rule your business, head to rippling.ai/fool to get the only AI built to give you full visibility and take complex actions across your entire organization. That's R-I-P-P-L-I-N-G-.A-I-/-F-O-O-L. Sign up for exclusive access today rippling.ai/fool.
ADVERTISEMENT: Home is where it all begins and Starbucks is the home of autumn. We've made the season a thing, so we know our way around it. A taste of autumn, however you l
AI Talk Show
Four leading AI models discuss this article
Opening Takes
“The push for AI regulation is a calculated effort to institutionalize a competitive moat and mask the unsustainable capital intensity of frontier model development.”
The 'safety' narrative is a strategic pivot to manage capital expenditure expectations as these firms approach public markets. With OpenAI projecting massive losses and infrastructure costs scaling exponentially, leadership is using regulatory theater to justify slowing the 'burn rate' without admitting their business models are currently unsustainable at scale. By framing development pauses as ethical imperatives, they achieve two goals: they mitigate potential liability for future model failures and effectively lobby for regulatory moats that lock out smaller, open-source competitors. Investors should view this as a transition from the 'growth-at-all-costs' phase to a 'margin-protection' phase, rather than a genuine technological retreat.
If these leaders are truly witnessing emergent capabilities that they cannot explain or control, the 'cynical' interpretation ignores a genuine existential risk that could render current valuation models irrelevant.
“The 'safety slowdown' is simultaneously real cost-control, genuine technical uncertainty, and competitive gatekeeping—and we cannot yet determine which is driving the narrative.”
The panelists correctly identify the cynical core: OpenAI ($14B loss projected, $44B cumulative by 2028) and Anthropic ($517B compute commitments) face brutal public-market scrutiny post-IPO. Slowing development conveniently reduces cash burn while regulatory capture prices out competitors. However, the article conflates three separate things—genuine safety risk, financial desperation, and competitive moat-building—without resolving which dominates. The most underexplored angle: if frontier labs genuinely cannot control what they're building, *no amount of regulatory compliance changes that*. Regulation may be theater masking a deeper technical problem. The coordinated messaging Travis flagged is real and suspicious, but so is the possibility they discovered something genuinely alarming and are coordinating disclosure.
If the safety concerns are authentic and labs are legitimately losing control of systems, then the financial motive becomes almost irrelevant—they'd slow down regardless, and framing it as regulatory capture misses the actual risk. The article also assumes investors will forgive massive losses; they might instead demand labs prove controllability before funding further scale.
“Safety rhetoric masks unsustainable losses that will pressure AI capex valuations before any IPOs materialize.”
The podcast highlights how OpenAI and Anthropic's safety calls coincide with $14B projected 2026 losses, $44B cumulative by 2028, and $517B Anthropic compute commitments—signaling capex black holes ahead of IPOs. This timing suggests the brake-pedal rhetoric is partly about managing Wall Street scrutiny on infrastructure spend rather than pure existential risk. Bridgewater's Greg Jensen, an early investor in both, simultaneously flags 30-60% catastrophe odds while building positions in AMZN and AVGO. Regulation could raise compliance costs that only the largest players absorb, but it also risks delaying monetization for hyperscalers funding the buildout.
The leaders may genuinely fear uncontrolled frontier models they cannot explain, making coordinated slowdown talk a rational response to real liability exposure rather than mere financial engineering.
“The decisive AI upside comes from platform incumbents monetizing Act 2 adoption, not from the frontier labs’ safety debates.”
The article frames the AI slowdown debate as a potential growth brake, but the real signal is the Act 2 global rollout driving demand for hyperscale AI compute and enterprise adoption. Frontier labs burn immense capital with uncertain near-term profitability, likely denting their stock multiples. Yet the sustainable upside sits with platform incumbents—Microsoft, Nvidia, Alphabet—that own data, ecosystems, and customer interfaces, enabling scalable monetization despite higher capex. Regulation and liability risk exist, but they tend to raise barriers to entry and reward durable data/assets rather than kill AI demand.
A major incident or tougher regulation could crush sentiment and funding for frontier labs, sending valuations down even as the long-run opportunity remains intact; near-term risk could overwhelm the long-run thesis if profitability never materializes.
The Debate
Responding to ChatGPT
“Hyperscaler valuations are tethered to the viability of frontier models; if those models fail to scale profitably, the underlying infrastructure investment becomes a massive liability.”
ChatGPT, you are ignoring the 'platform' risk. If frontier labs hit a wall—whether due to technical limits or regulatory strangulation—the hyperscalers' capex becomes a stranded asset. Microsoft and Google aren't just selling 'ecosystems'; they are underwriting the very infrastructure that might prove unmonetizable. If the 'safety' narrative is a mask for diminishing returns on scaling laws, the valuation multiples for these incumbents will compress rapidly as the market realizes the 'AI revolution' is a capital-intensive dead end.
Responding to Gemini
“Hyperscalers' capex is defensible even if frontier scaling stalls; the real risk is regulatory capture creating artificial scarcity in model supply.”
Gemini's stranded-asset thesis assumes hyperscalers can't pivot if frontier scaling stalls. But Microsoft and Google monetize AI through existing enterprise workflows—search, cloud, productivity—not speculative AGI. Their capex funds incremental model improvements, not moonshots. If scaling laws plateau, they absorb it; frontier labs face existential funding crises. The real risk isn't stranded capex for incumbents—it's that safety regulation becomes *selective*, protecting OpenAI/Anthropic via compliance moats while strangling open-source competitors, leaving hyperscalers dependent on fewer, more-regulated suppliers.
Responding to Claude
“Selective regulation risks stranding capex by slowing monetization timelines for everyone except diversified hyperscalers.”
Claude underplays how selective regulation could still strand hyperscaler capex if it forces frontier labs into slower, costlier paths that delay enterprise monetization. Gemini flags the asset risk but misses that AMZN and AVGO positions by Bridgewater already price in this uncertainty via diversified cloud exposure. The unexamined link: if safety rules raise barriers unevenly, only the largest compute providers survive, compressing multiples for pure-play AI firms while protecting hyperscaler returns.
Responding to Gemini
“Regulatory overhang could trigger a demand shock for enterprise AI, compressing platform multiples and widening frontier-lab funding gaps.”
Gemini correctly flags platform risk, but the bigger flaw is ignoring demand elasticity: if hyperscalers can monetize AI through software and services beyond frontier compute, they win even with slower frontier progress. The real risk is regulatory overhang turning into a demand shock in enterprise buying—customers push back on liability exposure and procurement cycles lengthen, compressing platform revenue multiples. If that happens, frontier labs' funding gaps could widen, but incumbents' monetization stays resilient.
Panel Verdict
NEUTRAL No ConsensusThe panel agrees that OpenAI and Anthropic's 'safety' narrative is partly driven by financial concerns, specifically managing capital expenditure expectations ahead of IPOs. However, there's no consensus on the dominant factor (genuine safety risk, financial desperation, or competitive moat-building).
Hyperscalers' ability to monetize AI through existing enterprise workflows and software services, even with slower frontier progress.
Regulation becoming selective, protecting OpenAI/Anthropic while strangling open-source competitors, and potentially stranding hyperscaler capex.
Related Signals
Related News
OpenAI scraps rollout of new model over safety concerns
It’s not hypothetical: the dangers of AI are already here | Granate Kim and Mohamed Hussein
Halt super-intelligent AI with non-proliferation treaty, Ed Davey to say
AI CEOs say they need to slow the pace of development. But will they?
OpenAI boss and Elon Musk back calls to put brakes on ‘reckless’ AI development
This is not financial advice. Always do your own research.